🇫🇷
France · FR · FR:61430397
RIVASTIGMINE EG LABO 9,5 mg/24 h, patch transdermique
ATC N06DA03
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerEG LABO - LABORATOIRES EUROGENERICS
CountryFR (France)
ATC codeN06DA03
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip13340093024301530 sachet(s) papier polytéréphtalate (PET) aluminium polyacrylonitrile avec fermeture de sécurité enfant de 1 patch transdermique
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "61430397",
"date_amm": "2021-11-26",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "patch",
"voies_administration": "transdermique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code N06DA03.
Access this data programmatically
Query RIVASTIGMINE EG LABO 9,5 mg/24 h, patch transdermique and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.